Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease

Movement Disorders

Volumn 25, Issue 13, 2010, Pages 2203-2210

  Djamshidian, Atbin ^a,b   Jha, Ashwani ^c   O'Sullivan, Sean S ^a   Silveira Moriyama, Laura ^a   Jacobson, Clare ^c   Brown, Peter ^c   Lees, Andrew ^a   Averbeck, Bruno B ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Impulse control disorder; Memory; Parkinson's disease; Risk and learning

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; AVERSION; CLINICAL ARTICLE; COMPULSION; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HUMAN; IMPULSIVENESS; LEARNING; MALE; NEGATIVE FEEDBACK; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; POSITIVE FEEDBACK; PRIORITY JOURNAL; TASK PERFORMANCE; TREATMENT RESPONSE; WORKING MEMORY;

AGED; ANALYSIS OF VARIANCE; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; LEARNING; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; RISK FACTORS;

EID: 78149469095     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23247     Document Type: Article

References (36)

1. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 2006;30:1-23.
2. Lewis SJ, Slabosz A, Robbins TW, Barker RA, Owen AM. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease. Neuropsychologia 2005;43:823-832.
3. Dagher A, Robbins TW. Personality, addiction, dopamine: insights from Parkinson's disease. Neuron 2009;61:502-510.
4. Lawrence AD, Evans AH, Lees AJ. Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry? Lancet Neurol 2003;2:595-604.
5. Weintraub D, Potenza MN. Impulse control disorders in Parkinson's disease. Curr Neurol Neurosci Rep 2006;6:302-306.
6. Brewer JA, Potenza MN. The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol 2008;75:63-75.
7. Voon V, Hassan K, Zurowski M, et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 2006;66:1750-1752.
8. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988;318:876-880.
9. Gotham AM, Brown RG, Marsden CD. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 1988;111(Pt 2):299-321.
10. Frank MJ, Seeberger LC, O'Reilly R C. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 2004; 306:1940-1943.
11. Torta DM, Castelli L, Zibetti M, Lopiano L, Geminiani G. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter? Brain Cogn 2009;71:84-91.
12. Evans AH, Katzenschlager R, Paviour D, et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004;19:397-405.
13. Wechsler D. Wechsler adult intelligence scale, Third ed. San Antonio: The Psychological Corporation; 1997.
14. Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 2006;442:1042-1045.
15. Averbeck BB, Duchaine B. Integration of social and utilitarian factors in decision making. Emotion 2009;9:599-608.
16. Huettel SA, Stowe CJ, Gordon EM, Warner BT, Platt ML. Neural signatures of economic preferences for risk and ambiguity. Neuron 2006;49:765-775.
17. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
18. O'Sullivan S, Djamshidian A, Evans A, Loane C, Lees AJ, Lawrence AD. Excessive hoarding in Parkinson's disease. Mov Dis 2010;25:1026-1033.
19. Mamikonyan E, Moberg PJ, Siderowf A, et al. Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord 2009;15:226-231.
20. Cools R, Sheridan M, Jacobs E, D'Esposito M. Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory. J Neurosci 2007;27:5506-5514.
21. Frank MJ, Santamaria A, O'Reilly RC, Willcutt E. Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2007;32:1583-1599.
22. Voon V, Reynolds B, Brezing C, et al. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) 2010;207:645-659.
23. Voon V, Pessiglione M, Brezing C, et al. Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 2010;65:135-142.
24. Evans AH, Pavese N, Lawrence AD, et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 2006;59:852-858.
25. Steeves TD, Miyasaki J, Zurowski M, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009;132(Pt 5):1376-1385.
26. Cools R, Barker RA, Sahakian BJ, Robbins TW. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 2003;41:1431-1441.
27. Williams GV, Goldman-Rakic PS. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995;376:572-575.
28. Voon V, Thomsen T, Miyasaki JM, et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 2007;64:212-216.
29. Todes CJ, Lees AJ. The pre-morbid personality of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1985;48:97-100.
30. Sher KJ, Bartholow BD, Wood MD. Personality and substance use disorders: a prospective study. J Consult Clin Psychol 2000;68:818-829.
31. Brand M, Kalbe E, Labudda K, Fujiwara E, Kessler J, Markowitsch HJ. Decision-making impairments in patients with pathological gambling. Psychiatry Res 2005;133:91-99.
32. Deakin J, Aitken M, Robbins T, Sahakian BJ. Risk taking during decision-making in normal volunteers changes with age. J Int Neuropsychol Soc 2004;10:590-598.
33. Abler B, Hahlbrock R, Unrath A, Gron G, Kassubek J. At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists. Brain 2009;132(Pt 9):2396-2402.
34. Bodi N, Keri S, Nagy H, et al. Reward-learning and the noveltyseeking personality: a betweenand within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain 2009;132(Pt 9):2385-2395.
35. McElroy SL, Keck PE Jr, Pope HG Jr, Smith JM, Strakowski SM. Compulsive buying: a report of 20 cases. J Clin Psychiatry 1994;55:242-248.
36. Voon V, Hassan K, Zurowski M, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006;67:1254-1257.